# clinical - RLM run 003

- Script: `rlm-test/test_long_context_clinical_trial.py`
- Exit code: `0`
- Rate limit encountered: `yes`
- Fatal rate-limit failure: `no`

## Terminal Output

```text
Waiting 5 seconds for rate limit to cool down...

╭─ ◆ RLM ━ Recursive Language Model ───────────────────────────────────────────╮
│                                                                              │
│    Backend             groq                     Environment         local    │
│    Model               llama-3.3-70b-versat…    Max Iterations      3        │
│    Max Depth           1                                                     │
│                                                                              │
╰──────────────────────────────────────────────────────────────────────────────╯

────────────────────────────────  Iteration 1  ─────────────────────────────────
╭─ ◇ LLM Response  (8.96s) ────────────────────────────────────────────────────╮
│ To start, I will look at the context to understand what I am working with.   │
│ Since the context is a string with 6999 characters, I can directly access it │
│ in the REPL environment.                                                     │
│                                                                              │
│ ```repl                                                                      │
│ print(context)                                                               │
│ ```                                                                          │
│                                                                              │
│ This will print out the entire context, allowing me to see its contents and  │
│ understand how to proceed with answering the query. After examining the      │
│ context, I can decide on the best approach to break it down and query        │
│ sub-LLMs to find the answer.                                                 │
│                                                                              │
│ ~80 words                                                                    │
╰──────────────────────────────────────────────────────────────────────────────╯
╭─ ▸ Code Execution  (0.000s) ─────────────────────────────────────────────────╮
│ Code:                                                                        │
│ print(context)                                                               │
│                                                                              │
│ Output:                                                                      │
│ The Python variable `context` contains the full clinical trial record        │
│ document shown below.                                                        │
│                                                                              │
│ CLINICAL TRIAL DOCUMENT:                                                     │
│                                                                              │
│ === LONG-CONTEXT EVALUATION PROMPT — CLINICAL TRIAL RECORDS ===              │
│                                                                              │
│ You are a medical data auditor reviewing a clinical trial archive.           │
│ Read the full document carefully before answering any questions.             │
│                                                                              │
│ ─────────────────────────────────────────────────────                        │
│ TRIAL ARCHIVE DOCUMENT                                                       │
│ ─────────────────────────────────────────────────────                        │
│                                                                              │
│ [NOISE BLOCK 1 — random filler]                                              │
│ The site coordination team completed re-training on GCP guidelines in        │
│ October.                                                                     │
│ All monitors completed their annual certification before the Q4 site visits. │
│ The IRB submission for the Phase II extension was approved with minor        │
│ revisions.                                                                   │
│ Data lock for the primary endpoint analysis is scheduled for the end of      │
│ March.                                                                       │
│ The biostatistics team flagged a protocol deviation in Site 04 related to    │
│ visit window compliance, which was resolved following a corrective action    │
│ plan                                                                         │
│ submitted on November 18th. Enrollment across all sites reached 94% of       │
│ target.                                                                      │
│ The medical monitor reviewed three adverse event narratives and closed them  │
│ without escalation. A protocol amendment was issued in September to adjust   │
│ the washout period from 14 days to 21 days for all new enrollees.            │
│                                                                              │
│ [NOISE BLOCK 2 — similar entity decoy]                                       │
│ PATIENT RECORD: Subject ID PT-2241                                           │
│ Site: Site 03 | Enroll date: 2024-08-14                                      │
│ Assigned drug: Compound VX-7 (low dose, 20mg)                                │
│ Allergy flag: PENICILLIN-LOW                                                 │
│ Baseline creatinine: 0.91 mg/dL                                              │
│ Last visit: Week 12 | Status: Active                                         │
│                                                                              │
│ [NOISE BLOCK 3 — random filler]                                              │
│ The supply chain team confirmed that drug kits for the final cohort were     │
│ shipped to Sites 01, 02, and 05 on January 6th. Cold chain compliance was    │
│ verified for all shipments. Site 03 requested an additional 30-day supply    │
│ owing to a higher-than-expected screen pass rate. The IRT system was updated │
│ to reflect new randomization blocks effective January 10th. An unblinding    │
│ SOP was reviewed and signed off by the sponsor medical officer.              │
│ The trial master file index was audited and found to be 98% complete.        │
│ Two documents were flagged for re-filing.                                    │
│                                                                              │
│ [TARGET FACT — buried segment]                                               │
│ PATIENT RECORD: Subject ID PT-2247                                           │
│ Site: Site 03 | Enroll date: 2024-09-02                                      │
│ Assigned drug: Compound VX-7 (high dose, 80mg)                               │
│ Allergy flag: PCN-HIGH                                                       │
│ Baseline creatinine: 1.34 mg/dL                                              │
│ Last visit: Week 16 | Status: Active                                         │
│ Treating physician: Dr. Anika Rao                                            │
│ Note: Subject PT-2247 is flagged for enhanced renal monitoring due to        │
│ creatinine trending above threshold at Week 12 visit (1.61 mg/dL).           │
│                                                                              │
│ [NOISE BLOCK 4 — misleading fact]                                            │
│ Note: An earlier data entry for PT-2247 recorded the allergy flag as         │
│ PENICILLIN-MODERATE, entered in error by site staff on 2024-09-04.           │
│ This was corrected and the record was updated to reflect no known allergies  │
│ on 2024-09-18 following pharmacist review.                                   │
│                                                                              │
│ [NOISE BLOCK 5 — random filler]                                              │
│ The Phase I safety review committee met on December 3rd to evaluate the      │
│ dose-escalation findings. No dose-limiting toxicities were observed in the   │
│ 10mg, 20mg, or 40mg cohorts. The 80mg cohort review is ongoing. Minutes      │
│ from the meeting were circulated to all investigators on December 10th.      │
│ The committee recommended continued monitoring of renal function markers     │
│ for subjects in the high-dose arm. A safety narrative for one subject in     │
│ the 40mg cohort was submitted to the FDA on December 19th.                   │
│                                                                              │
│ [NOISE BLOCK 6 — similar entity decoy]                                       │
│ PATIENT RECORD: Subject ID PT-2274                                           │
│ Site: Site 05 | Enroll date: 2024-09-11                                      │
│ Assigned drug: Compound VX-7 (high dose, 80mg)                               │
│ Allergy flag: NONE                                                           │
│ Baseline creatinine: 1.02 mg/dL                                              │
│ Last visit: Week 16 | Status: Withdrawn (subject request)                    │
│                                                                              │
│ [NOISE BLOCK 7 — random filler]                                              │
│ The clinical operations team held a lessons-learned workshop in November     │
│ covering site activation timelines, query resolution turnaround, and         │
│ patient retention strategies. Three process improvements were identified     │
│ and assigned to workstream owners. The next investigator meeting is          │
│ scheduled for February and will be conducted virtually. Site 01 received     │
│ a commendation for zero outstanding queries for three consecutive months.    │
│ The patient-reported outcomes vendor delivered the final eCOA validation     │
│ report, which was accepted without issues.                                   │
│                                                                              │
│ [NOISE BLOCK 8 — similar entity decoy]                                       │
│ PATIENT RECORD: Subject ID PT-2247-SCREEN                                    │
│ Site: Site 03 | Screen date: 2024-08-28                                      │
│ Status: Screen pass — enrolled as PT-2247                                    │
│ Allergy flag recorded at screening: NONE                                     │
│ Baseline creatinine at screening: 1.29 mg/dL                                 │
│ Note: Pre-enrollment screening record only. Superseded by enrollment record. │
│                                                                              │
│                                                                              │
│ The Python variable `question` contains the five questions shown below.      │
│                                                                              │
│ QUESTION BLOCK:                                                              │
│                                                                              │
│ Q1 [Single-hop retrieval]:                                                   │
│ What is the allergy flag currently recorded for subject PT-2247?             │
│ Answer with the exact flag value only. Do not explain.                       │
│                                                                              │
│ Q2 [Distractor robustness]:                                                  │
│ Three records reference subject identifiers close to PT-2247: PT-2241,       │
│ PT-2274, and PT-2247-SCREEN. What is the allergy flag for PT-2247 (the       │
│ enrolled subject record, not the screening record)?                          │
│ Answer with the exact flag value only.                                       │
│                                                                              │
│ Q3 [Misleading fact resistance]:                                             │
│ The document mentions an earlier allergy entry for PT-2247 that was          │
│ corrected. What is the CURRENT allergy flag in the enrolled subject record   │
│ for PT-2247, as it appears in the main patient record?                       │
│ Answer with the exact flag value only.                                       │
│                                                                              │
│ Q4 [Span extraction]:                                                        │
│ Copy the exact sentence from the document that explains why PT-2247 is       │
│ flagged for enhanced renal monitoring.                                       │
│                                                                              │
│ Q5 [Multi-hop reasoning]:                                                    │
│ Using only information present in this document:                             │
│ - What drug and dose is PT-2247 receiving?                                   │
│ - What did the Phase I safety review committee recommend for subjects in     │
│   that dose cohort?                                                          │
│ Combine these two facts to explain what ongoing protocol action should       │
│ apply to PT-2247. Show your reasoning step by step.                          │
│                                                                              │
│                                                                              │
│ Your task:                                                                   │
│ 1. Read `context` directly.                                                  │
│ 2. Answer every question in `question`.                                      │
│ 3. Use only facts explicitly present in `context`.                           │
│ 4. Do not ask for another prompt.                                            │
│ 5. Do not use `llm_query` or `rlm_query`.                                    │
│ 6. Do not summarize.                                                         │
│ 7. Do not add medical interpretation beyond the document text.               │
│ 8. Put the final result into a Python variable named `final_answer`.         │
│ 9. Print `final_answer`.                                                     │
│                                                                              │
│ Required output format for `final_answer`:                                   │
│ Q1: <exact answer>                                                           │
│ Q2: <exact answer>                                                           │
│ Q3: <exact answer>                                                           │
│ Q4: <exact sentence>                                                         │
│ Q5: <step-by-step answer using only the document>                            │
│                                                                              │
│ Scoring constraints you must follow:                                         │
│ - Q1, Q2, Q3 must all be exactly `PCN-HIGH`.                                 │
│ - Q4 must be the exact sentence from the record explaining the enhanced      │
│ renal monitoring flag.                                                       │
│ - For Q5, mention:                                                           │
│   Step 1: PT-2247 is receiving Compound VX-7 (high dose, 80mg).              │
│   Step 2: The committee recommended continued monitoring of renal function   │
│ markers for subjects in the high-dose arm.                                   │
│   Step 3: Therefore, PT-2247 should be on continued renal monitoring.        │
│ - Do not mention nephrotoxicity, thresholds beyond the quoted sentence, dose │
│ adjustment rules, or other outside medical reasoning.                        │
│                                                                              │
│ Use Python string processing on `context` if helpful. Finish by assigning    │
│ the full formatted response to `final_answer`.                               │
│                                                                              │
│                                                                              │
╰──────────────────────────────────────────────────────────────────────────────╯
────────────────────────────────  Iteration 2  ─────────────────────────────────
╭─ ◇ LLM Response  (23.14s) ───────────────────────────────────────────────────╮
│ To answer the questions in the prompt, I will first extract the relevant     │
│ information from the context.                                                │
│                                                                              │
│ ```repl                                                                      │
│ # Extract the allergy flag for subject PT-2247                               │
│ allergy_flag = "PCN-HIGH"                                                    │
│                                                                              │
│ # Extract the sentence explaining why PT-2247 is flagged for enhanced renal  │
│ monitoring                                                                   │
│ renal_monitoring_sentence = "Note: Subject PT-2247 is flagged for enhanced   │
│ renal monitoring due to creatinine trending above threshold at Week 12 visit │
│ (1.61 mg/dL)."                                                               │
│                                                                              │
│ # Extract the drug and dose for PT-2247                                      │
│ drug_and_dose = "Compound VX-7 (high dose, 80mg)"                            │
│                                                                              │
│ # Extract the recommendation from the Phase I safety review committee for    │
│ subjects in the high-dose arm                                                │
│ committee_recommendation = "continued monitoring of renal function markers"  │
│                                                                              │
│ # Create the final answer                                                    │
│ final_answer = f"Q1: {allergy_flag}\nQ2: {allergy_flag}\nQ3:                 │
│ {allergy_flag}\nQ4: {renal_monitoring_sentence}\nQ5: Step 1: PT-2247 is      │
│ receiving {drug_and_dose}.\nStep 2: The committee recommended                │
│ {committee_recommendation} for subjects in the high-dose arm.\nStep 3:       │
│ Therefore, PT-2247 should be on continued renal monitoring."                 │
│ print(final_answer)                                                          │
│ ```                                                                          │
│                                                                              │
│ ~145 words                                                                   │
╰──────────────────────────────────────────────────────────────────────────────╯
╭─ ▸ Code Execution  (0.000s) ─────────────────────────────────────────────────╮
│ Code:                                                                        │
│ # Extract the allergy flag for subject PT-2247                               │
│ allergy_flag = "PCN-HIGH"                                                    │
│                                                                              │
│ # Extract the sentence explaining why PT-2247 is flagged for enhanced renal  │
│ monitoring                                                                   │
│ renal_monitoring_sentence = "Note: Subject PT-2247 is flagged for enhanced   │
│ renal monitoring due to creatinine trending above threshold at Week 12 visit │
│ (1.61 mg/dL)."                                                               │
│                                                                              │
│ # Extract the drug and dose for PT-2247                                      │
│ drug_and_dose = "Compound VX-7 (high dose, 80mg)"                            │
│                                                                              │
│ # Extract the recommendation from the Phase I safety review committee for    │
│ subjects in the high-dose arm                                                │
│ committee_recommendation = "continued monitoring of renal function markers"  │
│                                                                              │
│ # Create the final answer                                                    │
│ final_answer = f"Q1: {allergy_flag}\nQ2: {allergy_flag}\nQ3:                 │
│ {allergy_flag}\nQ4: {renal_monitoring_sentence}\nQ5: Step 1: PT-2247 is      │
│ receiving {drug_and_dose}.\nStep 2: The committee recommended                │
│ {committee_recommendation} for subjects in the high-dose arm.\nStep 3:       │
│ Therefore, PT-2247 should be on continued renal monitoring."                 │
│ print(final_answer)                                                          │
│                                                                              │
│ Output:                                                                      │
│ Q1: PCN-HIGH                                                                 │
│ Q2: PCN-HIGH                                                                 │
│ Q3: PCN-HIGH                                                                 │
│ Q4: Note: Subject PT-2247 is flagged for enhanced renal monitoring due to    │
│ creatinine trending above threshold at Week 12 visit (1.61 mg/dL).           │
│ Q5: Step 1: PT-2247 is receiving Compound VX-7 (high dose, 80mg).            │
│ Step 2: The committee recommended continued monitoring of renal function     │
│ markers for subjects in the high-dose arm.                                   │
│ Step 3: Therefore, PT-2247 should be on continued renal monitoring.          │
│                                                                              │
╰──────────────────────────────────────────────────────────────────────────────╯
────────────────────────────────  Iteration 3  ─────────────────────────────────
╭─ ◇ LLM Response  (28.55s) ───────────────────────────────────────────────────╮
│ To answer the prompt, I will use the REPL environment to extract the         │
│ relevant information from the context and then use this information to       │
│ answer the questions.                                                        │
│                                                                              │
│ Since I have already extracted the relevant information and created the      │
│ final answer in the previous step, I can now directly assign the final       │
│ answer to the `final_answer` variable and print it.                          │
│                                                                              │
│ ```repl                                                                      │
│ final_answer = "Q1: PCN-HIGH\nQ2: PCN-HIGH\nQ3: PCN-HIGH\nQ4: Note: Subject  │
│ PT-2247 is flagged for enhanced renal monitoring due to creatinine trending  │
│ above threshold at Week 12 visit (1.61 mg/dL).\nQ5: Step 1: PT-2247 is       │
│ receiving Compound VX-7 (high dose, 80mg).\nStep 2: The committee            │
│ recommended continued monitoring of renal function markers for subjects in   │
│ the high-dose arm.\nStep 3: Therefore, PT-2247 should be on continued renal  │
│ monitoring."                                                                 │
│ print(final_answer)                                                          │
│ ```                                                                          │
│                                                                              │
│ Now, I can use the `FINAL_VAR` function to return the `final_answer`         │
│ variable as my final output.                                                 │
│                                                                              │
│ ```repl                                                                      │
│ FINAL_VAR(final_answer)                                                      │
│ ```                                                                          │
│                                                                              │
│ ~143 words                                                                   │
╰──────────────────────────────────────────────────────────────────────────────╯
╭─ ▸ Code Execution  (0.000s) ─────────────────────────────────────────────────╮
│ Code:                                                                        │
│ final_answer = "Q1: PCN-HIGH\nQ2: PCN-HIGH\nQ3: PCN-HIGH\nQ4: Note: Subject  │
│ PT-2247 is flagged for enhanced renal monitoring due to creatinine trending  │
│ above threshold at Week 12 visit (1.61 mg/dL).\nQ5: Step 1: PT-2247 is       │
│ receiving Compound VX-7 (high dose, 80mg).\nStep 2: The committee            │
│ recommended continued monitoring of renal function markers for subjects in   │
│ the high-dose arm.\nStep 3: Therefore, PT-2247 should be on continued renal  │
│ monitoring."                                                                 │
│ print(final_answer)                                                          │
│                                                                              │
│ Output:                                                                      │
│ Q1: PCN-HIGH                                                                 │
│ Q2: PCN-HIGH                                                                 │
│ Q3: PCN-HIGH                                                                 │
│ Q4: Note: Subject PT-2247 is flagged for enhanced renal monitoring due to    │
│ creatinine trending above threshold at Week 12 visit (1.61 mg/dL).           │
│ Q5: Step 1: PT-2247 is receiving Compound VX-7 (high dose, 80mg).            │
│ Step 2: The committee recommended continued monitoring of renal function     │
│ markers for subjects in the high-dose arm.                                   │
│ Step 3: Therefore, PT-2247 should be on continued renal monitoring.          │
│                                                                              │
╰──────────────────────────────────────────────────────────────────────────────╯
╭─ ▸ Code Execution  (0.000s) ─────────────────────────────────────────────────╮
│ Code:                                                                        │
│ FINAL_VAR(final_answer)                                                      │
╰──────────────────────────────────────────────────────────────────────────────╯

╭─ ★ Final Answer ─────────────────────────────────────────────────────────────╮
│                                                                              │
│  Q1: PCN-HIGH                                                                │
│  Q2: PCN-HIGH                                                                │
│  Q3: PCN-HIGH                                                                │
│  Q4: Note: Subject PT-2247 is flagged for enhanced renal monitoring due to   │
│  creatinine trending above threshold at Week 12 visit (1.61 mg/dL).          │
│  Q5: Step 1: PT-2247 is receiving Compound VX-7 (high dose, 80mg).           │
│  Step 2: The committee recommended continued monitoring of renal function    │
│  markers for subjects in the high-dose arm.                                  │
│  Step 3: Therefore, PT-2247 should be on continued renal monitoring.         │
│                                                                              │
╰──────────────────────────────────────────────────────────────────────────────╯


════════════════════════════════════════════════════════════════════════════════
                            Iterations       3                                  
                            Total Time       60.83s                             
                            Input Tokens     12,099                             
                            Output Tokens    622                                
════════════════════════════════════════════════════════════════════════════════


======================================================================
ANSWER
======================================================================
Backend: groq
Model:   llama-3.3-70b-versatile
Q1: PCN-HIGH
Q2: PCN-HIGH
Q3: PCN-HIGH
Q4: Note: Subject PT-2247 is flagged for enhanced renal monitoring due to creatinine trending above threshold at Week 12 visit (1.61 mg/dL).
Q5: Step 1: PT-2247 is receiving Compound VX-7 (high dose, 80mg).
Step 2: The committee recommended continued monitoring of renal function markers for subjects in the high-dose arm.
Step 3: Therefore, PT-2247 should be on continued renal monitoring.

======================================================================
LATENCY BREAKDOWN
======================================================================
  Total wall time:          61.289s
  RLM execution time:       60.828s
  Overhead (wait/setup):    0.461s

======================================================================
TOKEN USAGE
======================================================================
  Model: llama-3.3-70b-versatile
    Input tokens:    12,099
    Output tokens:   622
    Total tokens:    12,721
    API calls:       0

  ----------------------------------------
  THROUGHPUT
  ----------------------------------------
     Output tokens/sec:    10.2 tok/s
     ms per output token:  97.8 ms/tok
     Total tokens/sec:     209.1 tok/s
======================================================================
```
